JGGDR
ALNY icon

JGP Global Gestao de Recursos’s Alnylam Pharmaceuticals ALNY Stock Holding History

JGP Global Gestao de Recursos’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,546
Closed -$364K – 36
2024
Q4 		$364K Sell
1,546
-2
-0.1% -$526 0.83% 26
2024
Q3 		$426K Buy
1,548
+315
+26% +$82K 0.83% 23
2024
Q2 		$300K Buy
+1,233
New +$195K 0.38% 27
2024
Q1 		– Sell
-1,850
Closed -$354K – 63
2023
Q4 		$354K Sell
1,850
-6
-0.3% -$1.02K 0.21% 28
2023
Q3 		$329K Sell
1,856
-20
-1% -$3.82K 0.21% 32
2023
Q2 		$356K Sell
1,876
-16
-0.8% -$3.17K 0.25% 42
2023
Q1 		$379K Buy
1,892
+159
+9% +$33.4K 0.39% 31
2022
Q4 		$412K Sell
1,733
-4
-0.2% -$853 0.29% 37
2022
Q3 		$348K Buy
1,737
+246
+16% +$46.9K 0.29% 34
2022
Q2 		$217K Sell
1,491
-10
-0.7% -$1.42K 0.17% 48
2022
Q1 		$245K Buy
1,501
+199
+15% +$30.3K 0.14% 53
2021
Q4 		$221K Sell
1,302
-2
-0.2% -$372 0.1% 62
2021
Q3 		$246K Sell
1,304
-67
-5% -$12.6K 0.09% 64
2021
Q2 		$232K Buy
+1,371
New +$201K 0.08% 59
2020
Q4 		– Sell
-1,426
Closed -$208K – 47
2020
Q3 		$208K Sell
1,426
-87
-6% -$12.4K 0.11% 57
2020
Q2 		$224K Buy
+1,513
New +$204K 0.13% 53

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JGP Global Gestao de Recursos's ALNY Position: Q1 2025 in Review

JGP Global Gestao de Recursos sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2025, closing a stake of 1,546 shares — an estimated $364K sold.

JGP Global Gestao de Recursos first reported a position in ALNY in Q2 2020 and held it in 16 quarters. The position peaked at $426K in Q3 2024. 627 funds tracked by Wall St. Rank hold ALNY as of Q1 2025.

  • JGP Global Gestao de Recursos reported no remaining Alnylam Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 1,546 Alnylam Pharmaceuticals shares in Q1 2025, an estimated $364K.
  • JGP Global Gestao de Recursos first reported a position in Alnylam Pharmaceuticals in Q2 2020 and held it in 16 quarters.
  • JGP Global Gestao de Recursos's Alnylam Pharmaceuticals position peaked at $426K in Q3 2024.
  • 627 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2025.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2025, filed 9 May 2025.